Click on the bar plot to filter the table below.
Bubble size reflects the number of regulators (TFs/miRNA) in the network. Click on the bubble plot to filter the table below.
| Number | Tissue type | Methods | Regulator | Condition | Network types | Datasets |
|---|---|---|---|---|---|---|
| 1 | All | DRAGON | miRNA | Cancer | aggregate | CCLE |
| 2 | Fibroblast | PANDA, PUMA | TF, miRNA | Normal (primary) | aggregate | GTEx |
| 3 | LCL | PANDA, PUMA, EGRET | TF, miRNA | Normal (transformed) | aggregate | GTEx |
| 4 | Adrenal Cancer | LIONESS | TF | Cancer | single-sample | CCLE |
| 5 | Bile Duct Cancer | LIONESS | TF | Cancer | single-sample | CCLE |
| 6 | Bladder Cancer | LIONESS | TF | Cancer | single-sample | CCLE |
| 7 | Bone Cancer | LIONESS | TF | Cancer | single-sample | CCLE |
| 8 | Brain Cancer | LIONESS | TF | Cancer | single-sample | CCLE |
| 9 | Breast Cancer | LIONESS | TF | Cancer | single-sample | CCLE |
| 10 | Cervical Cancer | LIONESS | TF | Cancer | single-sample | CCLE |
| 11 | Colon/Colorectal Cancer | LIONESS | TF | Cancer | single-sample | CCLE |
| 12 | Embryonal Cancer | LIONESS | TF | Cancer | single-sample | CCLE |
| 13 | Endometrial/Uterine Cancer | LIONESS | TF | Cancer | single-sample | CCLE |
| 14 | Engineered | LIONESS | TF | Cancer | single-sample | CCLE |
| 15 | Esophageal Cancer | LIONESS | TF | Cancer | single-sample | CCLE |
| 16 | Eye Cancer | LIONESS | TF | Cancer | single-sample | CCLE |
| 17 | Fibroblast | LIONESS | TF | Cancer | single-sample | CCLE |
| 18 | Gallbladder Cancer | LIONESS | TF | Cancer | single-sample | CCLE |
| 19 | Gastric Cancer | LIONESS | TF | Cancer | single-sample | CCLE |
| 20 | Head and Neck Cancer | LIONESS | TF | Cancer | single-sample | CCLE |
| 21 | Kidney Cancer | LIONESS | TF | Cancer | single-sample | CCLE |
| 22 | Leukemia | LIONESS | TF | Cancer | single-sample | CCLE |
| 23 | Liposarcoma | LIONESS | TF | Cancer | single-sample | CCLE |
| 24 | Liver Cancer | LIONESS | TF | Cancer | single-sample | CCLE |
| 25 | Lung Cancer | LIONESS | TF | Cancer | single-sample | CCLE |
| 26 | Lymphoma | LIONESS | TF | Cancer | single-sample | CCLE |
| 27 | Myeloma | LIONESS | TF | Cancer | single-sample | CCLE |
| 28 | Neuroblastoma | LIONESS | TF | Cancer | single-sample | CCLE |
| 29 | Ovarian Cancer | LIONESS | TF | Cancer | single-sample | CCLE |
| 30 | Pancreatic Cancer | LIONESS | TF | Cancer | single-sample | CCLE |
| 31 | Prostate Cancer | LIONESS | TF | Cancer | single-sample | CCLE |
| 32 | Rhabdoid | LIONESS | TF | Cancer | single-sample | CCLE |
| 33 | Sarcoma | LIONESS | TF | Cancer | single-sample | CCLE |
| 34 | Skin Cancer | LIONESS | TF | Cancer | single-sample | CCLE |
| 35 | Teratoma | LIONESS | TF | Cancer | single-sample | CCLE |
| 36 | Thyroid Cancer | LIONESS | TF | Cancer | single-sample | CCLE |
| 37 | IPSC | EGRET, PANDA | TF | Normal | aggregate | Banovich et al. |
| 38 | IPSC-Cardiomyocyte | EGRET, PANDA | TF | Normal | aggregate | Banovich et al. |
| 39 | K562 | EGRET | TF | Normal | aggregate | ENCODE |
| 40 | GM12878 | EGRET | TF | Normal | aggregate | ENCODE |